Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.
Sena LA, Kumar R, Sanin DE, Thompson EA, Rosen DM, Dalrymple SL, Antony L, Yang Y, Gomes-Alexandre C, Hicks JL, Jones T, Bowers KA, Eskra JN, Meyers J, Gupta A, Skaist A, Yegnasubramanian S, Luo J, Brennen WN, Kachhap SK, Antonarakis ES, De Marzo AM, Isaacs JT, Markowski MC, Denmeade SR.
Sena LA, et al. Among authors: yegnasubramanian s.
J Clin Invest. 2022 Dec 1;132(23):e162396. doi: 10.1172/JCI162396.
J Clin Invest. 2022.
PMID: 36194476
Free PMC article.